Dr. med. Melanie Hagen



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

The why, what, who and when of B cell depletion in systemic lupus erythematosus: biological rationale, patient stratification and evolving therapeutic modalities (2026) Wincup C, Gatto M, Scherlinger M, Schett G, Hagen M Journal article, Review article Progress and promise of CAR-T cell treatment in autoimmune diseases (2026) Bachl J, Hagen M, Schett G Journal article Real-world longitudinal assessment of anifrolumab in patients with systemic lupus erythematosus: clinical outcomes, safety and modulation of cytokines and neutrophil activity (2026) Temiz A, Noversa de Sousa R, Schoen J, Reichardt C, Standfest K, Wirsching A, Hagen M, et al. Journal article Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases (2026) Düsing C, Györfi AH, Stütz AN, Lahu LM, Deicher FS, Li YN, Bruch PM, et al. Journal article BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease (2025) Bucci L, Böltz S, Hagen M, Tur C, Nöthling DM, Rothe T, Wirsching A, et al. Journal article Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with refractory systemic lupus erythematosus – Authors' reply (2025) Hagen M, Müller F, Wirsching A, Kharboutli S, Spörl S, Düsing C, Krickau T, et al. Journal article BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells (2025) Müller F, Wirsching A, Hagen M, Völkl S, Tur C, Raimondo MG, Taubmann J, et al. Journal article Langzeitverlauf von Effizienz und Sicherheit der CD19-CAR T-Zell-Therapie beim systemischen Lupus erythematodes (2025) Taubmann J, Böltz S, Hagen M, Wirsching A, Müller F, Völkl S, Kharboutli S, et al. Journal article Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus (2025) Garantziotis P, Beretta L, Lindblom J, Moysidou GS, Nikolopoulos D, Grieshaber Bouyer R, Hagen M, et al. Journal article Effects of different B-cell-depleting strategies on the lymphatic tissue (2025) Tur C, Eckstein M, Bucci L, Auth J, Bergmann C, Rauber S, Hagen M, et al. Journal article